SIR,-Many consultant histopathologists will probably have already formulated misgivings about the new national cervical cytology request form and will agree with the comments made by Dr J V Clark and Mr A J Sharp. ' The change in some numbering codes will certainly cause short term chaos in many computerised laboratories and make the retrieval of data for statistical returns extremely difficult. Reverse printing on the new form will also cause major problems in laboratories using the original blank area for vital records, but I understand that the Department of Health will consider providing a variant without such printing if a sufficient number of representations is received.
There has been a vital omission of clinical and medicolegal importance in that no SIR,-I agree with Dr J V Clark and Mr A J Sharp that the new HMR101/5 cervical cytology request form is far from satisfactory.' It seems that it has been designed more for collecting statistical information than for providing an effective means of communication between clinicians and cytology departments.
In addition to the deficiencies pointed out by Dr Clark and Mr Sharp I regret the deletion of severe inflammatory change (number 1 in box 24 on the old form). In my experience most inflammatory changes seen in smears are non-specific, and in an appreciable proportion of these smears there will be underlying cervical intraepithelial neoplasia. I can only suppose that such smears should now be classified as borderline in box 22. I do not regard the terms as synonymous and therefore consider this to be unsatisfactory.
Furthermore The patient group was defined solely on the basis of receipt of a renal allograft; the selection procedure made no reference to previous cervical pathological findings or to the history of smears. This is entirely appropriate in a controlled comparison provided the same criteria are applied to selecting controls, for the two groups may then reasonably be considered to be drawn from the same base population. Such a study would provide estimates for cervical disease in a mixed population (screened/unscreened, past pathological findings/ no past findings) and these estimates could be compared directly between the patient and control groups. However, the controls in this study could be selected only if: (a) they had had at least one cervical smear within the past two years, (b) all such smears were normal, and (c) they had no history of cervical intraepithelial neoplasia. These criteria, which were specific to the controls, might well have led to a systematic selection bias in the primary results.
Excluding patients with known cervical disease will inevitably reduce the observed prevalence of cervical abnormality among the controls. In addition, since most cases of cervical neoplasia in the general population occur in women who have never had cervical smears2 it might be expected that the transplant group, of whom 29% (14) had never had a smear, would appear to have a higher proportion with cervical pathological findings.
The authors appear to acknowledge the noncomparability of the two patient groups: "when those with abnormal smears were excluded (to make the [transplant] group comparable to the control group) 42% had neoplasia compared with 10% of the controls." As the sole reason for having controls is to provide a valid comparison group, however, it would have been preferable to ensure comparability throughout the primary analysis rather than to refer to it in a brief comment in the discussion. Furthermore, these exclusions will not necessarily ensure comparability and we would be interested to know whether the apparent excess of cervical pathological findings in the transplant group still remained after removal of the 14 previously unscreened women and the four with a known history of cervical intraepithelial neoplasia. We are not suggesting that the conclusions of this study are necessarily wrong but merely highlighting important methodological issues which may greatly distort results and which must be considered in designing studies of this type.
AUTHORS' REPLY, -In selecting our control group we considered our priority to be that all women should as far as possible be immunologically normal, and within such a group we attempted to match for the many factors known to be causally related to cervical intraepithelial neoplasia such as age, age at first intercourse, number of partners, use of oral contraception, and smoking habits. We did not attempt to select a group that was completely representative of the general population, and to have tried to do so while matching for smear history and cervical pathology as well as the above variables would, we believe, have introduced insuperable difficulties.
We concede that in our primary analysis we did not stratify the renal transplant group with respect to previous cytopathological findings in making our comparison with the controls, and it would indeed have been preferable to have done so. When we did this, to achieve the comparability suggested by Drs Kurinczuk and Burton, the final analysis showed very little difference from the original. Thus in the subgroup of 14 previously screened women and four with a known history of cervical intraepithelial neoplasia 10 (56%) had cervical intraepithelial neoplasia and in the screened subgroup of 31 women 13 (42%) had cervical intraepithelial neoplasia compared with the prevalence among the controls of 7 out of 69 (10%).
In conclusion, therefore, we agree that differences in the history of smears between the two groups might have introduced a slight selection bias. Nevertheless, this appears to have been a very small effect as the appreciable differences between the two groups were sustained.
